Camurus AB: Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Phase 3 Results for Long-acting ...Business Wire (press release)The present Phase 3 trial was a multicenter, randomized, double blind, double dummy, active controlled study that enrolled
